Neonatal outcomes and congenital malformations in children born after human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles.

Jie ZhangXiaoyan MaoYun WangQiuju ChenXuefeng LuQingqing HongYanping Kuang

Published in: Archives of gynecology and obstetrics (2017)

Our data suggested that compared with conventional ovarian stimulations, hMG + MPA treatment neither compromised neonatal outcomes of IVF newborns, nor did increase the prevalence of congenital malformations.

Keyphrases

endothelial cells
young adults
pregnant women
gestational age
type diabetes
machine learning
big data
artificial intelligence
replacement therapy
deep learning
cord blood